We acknowledge that the UBC Vancouver campus is situated on the traditional, ancestral, and unceded territory of the xʷməθkʷəy̓əm (Musqueam).
Eugenia Oviedo-Joekes
Eugenia Oviedo-Joekes
Professor PhD, Tier 1 Canada Research Chair
604 822 2772
eugenia@cheos.ubc.ca
2206 East Mall Vancouver, BC V6T 1Z3
About
I obtained a degree in clinical psychology at the University of Cordoba (Argentina), a PhD in social psychology and behavioural sciences methodology in Spain, and completed post-doctoral studies at the Andalusian School of Public Health. There, I conducted research on substance use and public health, and was part of a clinical trial testing pharmaceutical-grade heroin for opioid use disorder.
I moved to Canada in 2006 to join Dr. Schechter’s research program and became an Investigator on the NAOMI study, North America’s first heroin-assisted treatment trial. I have led the SALOME study, testing injectable hydromorphone for opioid use disorder, and provided evidence to expand injectable opioid agonist treatment across Canada.
Tier 1 Canada Research Chair in Person-Centered Care in Addiction and Public Health
Providence Health Care Research and Mission Award (2016)
Faculty of Medicine Distinguished Achievement Awards: Excellence in Clinical or Applied Research (2016)
CIHR New Investigator Award (2013)
Editorial Board, BMC Public Health
Scientist, Centre for Advancing Health Outcomes
Dr. Oviedo-Joekes’s main research area is public health and substance use, with a focus on innovative treatments for opioid use disorder for people that are not reached by the health care system by optimizing the uptake and effectiveness of these treatments using a person-center approach.
She is currently part of several Canadian Institutes of Health Research-funded grants; formerly co-investigator of North America’s first heroin-assisted treatment trial, the North American Opiate Medication Initiative (NAOMI); and formerly the principal investigator of the Study to Assess Long-Term Opioid Maintenance Effectiveness (SALOME), a randomized clinical trial that tested innovative treatments for severe, long-term opioid dependency. She is also the principal investigator of the GeMa (Gender Matters) study, which evaluates gender patterns of drug use, access to care, and health among long-term opioid users; a co-investigator of The Cedar Project, a cohort of young Aboriginal people using drugs; and the principal investigator of the Program of Outcomes Research on Treatment with Injectables for Addiction (PORTIA).
SPPH 550 – Public Health Approaches to Substance Use and Addictions